Next Article in Journal
Multi-Omics Analyses Reveal the Antifungal Mechanism of Phenazine-1-Carboxylic Acid Against Pseudogymnoascus destructans
Previous Article in Journal
Extracellular Phosphate Availability Impacts Aspergillus terreus Itaconic Acid Fermentation via Biomass-Specific Product Yield
Previous Article in Special Issue
Yeast Species Associated with Industrial Cultures of the Marine Microalgae Tisochrysis lutea: Temperature Profiles and Auxin Production
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Zinc-Finger 5 Is an Activation Domain in the Saccharomyces cerevisiae Stress-Responsive Transcription Factor Fzf1

Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada
*
Author to whom correspondence should be addressed.
J. Fungi 2026, 12(1), 15; https://doi.org/10.3390/jof12010015 (registering DOI)
Submission received: 25 May 2025 / Revised: 21 December 2025 / Accepted: 22 December 2025 / Published: 25 December 2025
(This article belongs to the Special Issue Stress Tolerance in Yeast Biotechnology)

Abstract

Fzf1 is a Saccharomyces cerevisiae transcription factor that contains five zinc finger domains (ZF1-5) and induces the expression of at least five genes in response to various chemical stresses by recognizing the shared promoter consensus sequence CS2. The N-terminal ZF1-3 are required and sufficient for binding to CS2, while ZF4 negatively regulates the activity of Fzf1. However, the effect of ZF5 on the activity of Fzf1 is not well defined. In this study, substitutions of the two zinc-coordinating Cys residues (C248S and C253S) of ZF5, or deletion of the whole ZF5 domain, compromised the chemical stress-induced activation of Fzf1. Since the elevated Fzf1-regulated gene expression caused by fzf1-ZF4 could also be reversed by additional deletion of ZF5 or C248S/C253S substitutions, fzf1-ZF5 mutations are epistatic over fzf1-ZF4 mutations. Furthermore, fzf1-ZF5 mutations are recessive to FZF1, while ZF5 is dispensable for the CS2 binding. Finally, Fzf1-ZF5 is required and sufficient to serve as a transcription activation domain when fused to a Gal4 DNA-binding domain. These observations collectively support a working model in which Fzf1 bound to its target gene promoters remains inactive due to an inhibitory activity of ZF4. Upon chemical stress, ZF4 is no longer able to inhibit the ZF5 transactivation activity, leading to the induction of Fzf1-regulated gene expression and subsequent chemical detoxification.

1. Introduction

Saccharomyces cerevisiae FZF1 encodes a transcription factor that contains five zinc-finger (ZF) domains [1] (Supplementary Figure S1), and its highly conserved homologs can be found in lower eukaryotes, including but not limited to Saccharomyces, Candida, and Kluyveromyces, but are absent in higher eukaryotes. Fzf1 orchestrates expressions of target genes including SSU1, YHB1, DDI2, DDI3 (DDI2/3), and YNR064C [2,3]. These genes are known for their response to a variety of chemical stimuli with a common theme of chemical stress tolerance. SSU1 encodes a plasma membrane protein responsible for sulfite efflux [4]. YHB1 encodes a dioxygenase participating in oxidative stress responses, particularly those mediated by nitric oxide (NO) [5]. It is worth noting that YHB1 expression can be induced by NO and NO-derived compounds such as dipropylenetriamine (DPTA) NONOate, a commonly used experimental NO donor [6]. DDI2/3 encode cyanamide (CY) hydratases [7,8] and can be induced by CY [8,9] or methyl methanesulfonate (MMS) [10], a DNA-damaging agent and potential methyl donor to macromolecules [11]. YNR064C encodes an epoxide hydrolase [12]. Overexpression of FZF1 led to the induction of all five Fzf1-regulated genes [2], while deletion of FZF1 abolished the chemical induction of these genes [3,13]. These observations collectively highlight the role of FZF1 as a positive regulator for its downstream gene expression. It has been suggested by sequencing alignment and subsequently demonstrated that a conserved promoter element, named as consensus sequence 2 (CS2, 5′-AAATGATAGTNANC-3′, where “N” can be any nucleotides) present in all five Fzf1-regulated genes, is required for chemically induced YHB1 and DDI2/3 expression [2,13], highlighting the critical regulatory role of this sequence. Furthermore, in vitro and in vivo assays confirmed that Fzf1 directly binds the CS2 sequence from DDI2/3 promoters [13] and other CS2 sequences [14], establishing CS2 as the specific DNA-binding target of Fzf1.
All five ZFs in Fzf1 belong to the Cys2His2 (C2H2) zinc finger family [15], which typically coordinate a tetrahedral zinc ion through two Cys and two His residues, positioning an α-helix into the major groove of duplex DNA [16]. Traditionally, each C2H2 zinc finger is thought to recognize a triplet of nucleotides [17]; however, Fzf1 has been characterized as a noncanonical C2H2 zinc finger protein [14]. A previous in vitro study [18] demonstrated that the N-terminal three zinc fingers (ZF1-3) are primarily responsible for recognizing the target DNA sequence in the SSU1 promoter [18]. A recent CS2-bound Fzf1 crystal structural analysis [14] revealed that ZF1-3 is required and sufficient to recognize CS2. Since ZF4 and ZF5 appear to be dispensable for the CS2 binding, we proposed that they function as regulatory elements within Fzf1. Indeed, some previous studies [19,20] found that several single amino acid substitutions within Fzf1-ZF4 activated its selected downstream genes, and our recent studies demonstrated that ZF4 indeed serves as a repressor domain within Fzf1 [3], suggesting that ZF4 inhibits the Fzf1 activity in the absence of stimuli, and that the chemical induction is actually achieved through derepression.
When ZF4 is mutated or deleted, Fzf1 remains constitutively active, as judged by increased basal level expression of its target genes. Which element within Fzf1 is required to support such an activity? During our characterization of Fzf1-ZF4 functions, we observed that Fzf1 ZF1-3 alone, although capable of binding CS2, failed to activate its target gene despite chemical treatments [3], raising the possibility that ZF5, or other deleted residues in the construct, functions as an activator. Consistently, two Cys-to-Ser substitutions within the ZF5 domain abolished NO-induced YHB1 expression [20]. Based on these observations, we hypothesized that ZF5 functions as a transcription activation domain (TAD) in Fzf1. To test this hypothesis, we created deletions and corresponding amino acid substitutions within Fzf1-ZF5 and assessed their phenotypes. Furthermore, Fzf1 and its various truncations were fused to a heterologous Gal4 DNA-binding domain (Gal4BD), and their transactivation activity was measured by reporter gene assays. These studies collectively demonstrated that ZF5 is required and sufficient to function as an activation domain.

2. Materials and Methods

2.1. Yeast Strains, Cell Culture, and Chemical Treatments

All haploid yeast strains used in this study were derived from BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0). The isogenic fzf1Δ::KanMX4 strain utilized in this study was from the yeast gene deletion collection. Yeast cells were cultured in yeast extract-peptone-dextrose (YPD) medium or synthetic dextrose (SD) medium supplemented with appropriate nutrients, as previously described [21].
For the chemical treatments, yeast cells were cultured in YPD or SD selective medium at 30 °C overnight. Then the cultures were inoculated into a fresh medium and grown for approximately 2 h until reaching an optical density of 0.2–0.3 at 600 nm (OD600). Cells were then treated with optimal concentrations of test chemicals, including 20 mM CY, 0.05% MMS, or 5 mM sodium sulfite supplemented with 75 mM tartaric acid (TA), for 2 h. For the NO treatment, DPTA NONOate was freshly dissolved in double-distilled water (ddH2O) to prepare a 0.1 M stock solution immediately before adding it to the culture medium, and cells were treated for 1.5 h. Untreated control cells were incubated under identical conditions.

2.2. Plasmid Construction and Site-Specific Mutagenesis

The YCpL-FZF1 plasmid utilized in this study was as described previously [3]. Desired fzf1-ZF5 mutations, including fzf1-C248S, fzf1-C253S, fzf1-C157S, C248S and fzf1-C157S, C253S (Supplementary Table S1), were generated by site-directed mutagenesis following a modified QuickChange protocol [22], using YCpL-FZF1 and YCpL-fzf1-C157S as templates. Mutations were generated by PCR amplification of the plasmid using corresponding mutagenic primers (Table S2), followed by DpnI digestion to remove the methylated template DNA. The resulting PCR products were transformed into Escherichia coli DH10B cells for selection of clones containing desired mutations. To make Fzf1 truncations in plasmid YCpL-FZF1, the same QuickChange protocol was followed except using overlapping truncation primers (Table S2). All FZF1-related mutations or truncations were confirmed by DNA sequencing.

2.3. Yeast Cell Transformation

Yeast cells were transformed with plasmids using a lithium acetate method [23] as described [24].

2.4. Yeast Survival Assay

Sulfite resistance was assessed by a serial dilution assay as previously described [25]. Plates containing 75 mM TA and different concentrations of sodium sulfite were prepared as described [3].

2.5. Yeast RNA Extraction and Quantitative Reverse Transcription PCR (qRT-PCR)

After chemical treatments, cells were harvested by centrifugation and subjected to enzymatic lysis by using 200 U of zymolyase (Amsbio, Cambridge, MA, USA, Cat. 120491-1) per 5 × 107 yeast cells for 1 h. Total RNA was extracted from yeast cells using the Yeast RNA Extraction kit (Geneaid, New Taipei City, Taiwan, Cat. RBY300). The extracted RNA samples were then reverse transcribed into cDNA for long-term use, and gene expression levels were quantified by quantitative PCR with iQ™ SYBR Green Supermix (Bio-Rad, Mississauga, ON, Canada, Cat. 170-8882). Data analysis was performed using the 2−ΔΔCT method as described [26] to determine relative expression levels of target genes normalized to the internal reference gene UBC6, as previously validated [13]. All experiments were repeated at least three times, and the results were analyzed by two-way ANOVA and presented in GraphPad.

2.6. Western Blot Analysis

Protein levels of Fzf1 and a ZF5 deletion variant Fzf1-∆ZF5 in yeast cells were assessed by Western blot analysis. Fzf1-∆ZF5-Flag was constructed into plasmid YCplac111 [27] using C-terminally tagged 3xHA, 3xFlag, and His6 (YCpL-FZF1-HFH) as a template by PCR amplification using overlapping truncation primers (Table S2) followed by DpnI digestion [28]. To make N-terminally tagged constructs, Primer pairs (Table S2) encoding 3xFlag were used for the QuickChange reaction to be inserted at the 5′ ORF of FZF1 in plasmid YCpL-FZF1 to form YCPl-3Flag-FZF1, followed by site-directed mutagenesis as previously described to introduce desired mutations. To clone these mutations into a multi-copy plasmid, the entire FZF1 ORF with its native promoter, terminator, and 3xFlag coding sequences was cloned into YEplac181 [27]. Total yeast proteins were extracted using a glass bead method [29], and tagged proteins were detected using an anti-Flag antibody (Sigma, Oakville, ON, Canada, Cat. F1804, 1:5000 dilution). An anti-Pgk1 polyclonal antibody received from Dr. W. Li (Institute of Zoology, Chinese Academy of Sciences) served as an internal control. To quantify relative protein levels, 3xFlag-Fzf1 protein band intensity was measured by densitometry and analyzed by an Image J software (v 1.54r).

2.7. Yeast Reporter Gene Assays

To investigate the transcription activation ability of Fzf1 and its various domains, desired FZF1 coding sequences were PCR amplified using different primers (Table S2), all containing a BamHI restriction site. After cleavage by BamHI, these DNA fragments were cloned into the BamHI site of plasmid pGBT9 [30] to be fused in-frame with the Gal4BD coding sequence. The desired plasmids (Table S1) were screened and confirmed by DNA sequencing of the entire coding region and transformed into a yeast two-hybrid strain PJ69-4a (MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ MET2::PGAL7-lacZ::PGAL1-HIS3a::PGAL2-ADE2) [31]. The transformants growing on the SD-Trp plate were spotted to SD-Trp-His plus various amounts of 3-amino-1, 2, 4-triazole (3AT, Sigma A8056) to assess the fusion gene’s ability to activate the PGAL1-HIS3 reporter gene. Alternatively, transformants growing on SD-Trp plates were used to inoculate liquid SD-Trp medium. An overnight culture was diluted into fresh selective medium to OD600 = 0.2 and cultured for another 2 h, followed by chemical treatments as described above. A β-galactosidase (β-Gal) assay was performed as described using ortho-nitrophenyl-β-galactoside (ONPG) as a substrate and the enzymatic product yield was measured at OD420 nm [32].

2.8. Recombinant Fzf1-N117 Protein Production and Purification

To make a C-terminal truncation, a pair of deletion primers Fzf1-N117F/N117R (Table S2) was used to perform QuickChange mutagenesis with plasmid pGEX-FZF1 [3] as the template. The resulting plasmid, pGEX-fzf1-N117, was transformed into E. coli Rosetta cells and the recombinant protein was induced by 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The bacterial cells were then lysed, and the DNA and RNA contaminants were digested using nuclease benzonase (Thermo Scientific, Mississauga, ON, Canada, Cat. 11442587). The protein was subsequently subjected to glutathione sepharose 4B beads affinity purification (Cytiva, Vancouver, BC, Canada, Cat. 45-002-065). The N-terminal GST tag was then removed by PreScission protease, and the cleaved protein was further purified via an additional round of glutathione sepharose beads to remove GST-tagged PreScission protease, followed by the final purification step with heparin beads (Heparin Sepharose™ 6 Fast Flow, Cytiva, Vancouver, BC, Canada, Cat. 17099801). The purity and concentration of the resulting Fzf1-N117 protein were assessed prior to applications.

2.9. Electrophoresis Mobility Shift Assay (EMSA)

Each EMSA reaction contained 0.1 pmol of double-stranded DNA (dsDNA) probe, annealed by one fluorescein isothiocyanate (FITC)-labeled strand and one unlabeled complementary strand (Table S2), 2 ng of bovine serum albumin (BSA), 0.5 µg of poly dI-dC (Thermo Scientific, Mississauga, ON, Canada, Cat. 11430605), dissolved in the EMSA binding buffer. The DNA probe and protein were incubated for 20 min on ice prior to adding poly dI-dC. The macromolecules were then resolved in a 6% native polyacrylamide gel and visualized by detecting the FITC fluorescence at 488 nm.
To determine the dissociation constant (Kd), the EMSA band intensities were quantified using Adobe Photoshop by measuring both the shifted (protein–DNA complex) and unshifted (free probe) bands. The binding percentage was calculated as previously described [3]:
Binding (%) = [Shifted Band Intensity/(Shifted + Free Band Intensity)] × 100%.
The binding saturation point was generated by the relative binding percentage at each concentration, then normalized into the maximum observed binding (saturated binding level):
Normalized Binding (%) = (Observed Binding/Saturated Binding) × 100%.
Binding curves were generated using GraphPad Prism software (version 9.5.0) by fitting the data to the “[Agonist] vs. Normalized Response” equation as described:
Binding (%) = 100 × [Protein molar concentration]/(Kd + [Protein molar concentration]).

3. Results

3.1. fzf1-ZF5 Is Intragenically Epistatic to fzf1-ZF4

To test a hypothesis that Fzf1-ZF5 serves as a positive regulation domain, we made fzf1-C248S and fzf1-C253S mutations and an fzf1-∆ZF5 truncation in YCpL-FZF1 [13] by site-directed mutagenesis, as illustrated in Figure 1A, transformed into fzf1∆ mutant cells, and measured Fzf1-regulated gene expression. The DDI2/3, SSU1, YHB1, and YNR064C transcript levels remained low in wild-type and fzf1-ZF5 mutants (Figure 1B). Interestingly, under conditions that a fzf1-ZF4 mutation (fzf1-C157S) dramatically increased DDI2/3, SSU1, YHB1, and YNR064c basal-level expression, as previously reported [3], fzf1-C248S and fzf1-C253S point mutations reduced the expression of these genes to levels indistinguishable from that of corresponding fzf1-ZF5 mutants alone (Figure 1B), indicating that ZF5 is required to support the basal-level expression of Fzf1-regulated genes in the absence of chemical stresses.
Furthermore, plasmids carrying the fzf1-ZF5 point mutations were transformed into both wild-type and its fzf1∆ mutant cells, and their sulfite resistance phenotypes were assessed by a serial dilution assay using FZF1 and fzf1-C157S as references. Figure 1C shows that while the fzf1-C157S transformant was highly resistant to sulfite, FZF1, fzf1-C248S, and fzf1-C253S transformed cells remained sensitive to sulfite, consistent with our observation that the SSU1 expression was not elevated in these cells (Figure 1B). Interestingly, the fzf1-C157S, C248S and, fzf1-C157S, C253S double mutants, displayed phenotypes indistinguishable from those of fzf1-C248S and fzf1-C253S single mutants regardless of the presence or absence of a wild-type FZF1 gene (Figure 1C). We also made various Fzf1 truncations in plasmid YCpL-FZF1 and found that deletion of ZF4 alone (∆ZF4, missing aa99-182) caused strong sulfite resistance, while deletion of ZF5 alone (∆ZF5, missing aa183-299) or both ZF4 and ZF5 (N99, N109 and N117, containing Fzf1 N-terminal region up to the indicated amino acid residues) remained sensitive to sulfite in both wild-type and fzf1∆ backgrounds (Figure 1D). Since fzf1-ZF4,5 dual mutations and deletions behaved like their corresponding fzf1-ZF5 single mutants and differed from fzf1-ZF4 single mutants with respect to both target gene expression (Figure 1B) and sulfite sensitivity (Figure 1C,D), fzf1-ZF5 mutations are intragenically epistatic to fzf1-ZF4, indicating that all fzf1-ZF5 alleles are loss-of-function mutations.

3.2. fzf1-C248S and fzf1-C253S Differentially Affect Fzf1-Regulated Gene Expressions in Response to Chemical Stresses

If ZF5 is a positive regulatory element within Fzf1, the Fzf1-dependent induction of downstream genes upon chemical treatments is expected to be abolished in these mutants. To test this hypothesis, various chemical treatments were applied to fzf1∆ cells harboring a single copy of the FZF1 derivative. It has been previously reported [3] that such a reconstituted system faithfully represented the endogenous FZF1 activity, as judged by its downstream gene induction upon chemical treatments. Unlike wild-type cells that responded to chemical treatments with characteristic transcriptional profiles (Figure 2A), fzf1-∆ZF5 transformed cells barely responded to various chemical treatments, as evident by their downstream gene expression patterns (Figure 2B). Similarly, the fzf1-C248S mutant also displayed compromised transcriptional response to all chemical treatments (Figure 2C) in patterns like that of fzf1-∆ZF5 (cf. Figure 2B,C), indicating that fzf1-C248S is a complete loss-of-function mutation. To our surprise, the fzf1-C253S mutant displayed rather different induction patterns, in which DDI2/3 was still induced more than 20-fold by CY, and YNR064C was induced approximately 50-fold by NO (Figure 2D). Hence, fzf1-C253S is not a complete FZF1 loss-of-function mutation. Interestingly, the fzf1-C253S mutant phenotype is reminiscent of previously reported fzf1-ZF4 mutants that, in addition to the increased basal-level gene expression, only DDI2/3 can be further induced by CY, and YNR064C can be further induced by NO [3], albeit at different fold induction levels.

3.3. FZF1 Is Dominant over fzf1-ZF5 Mutations

If fzf1-ZF5 is a loss-of-function mutation, it is then expected to be recessive to FZF1. To test this hypothesis, YCp plasmids carrying fzf1-ZF5 mutations were transformed into a wild-type strain so that the transformants carried one copy of FZF1 on the chromosome, plus one copy of the fzf1-ZF5 mutant allele in a plasmid. The Fzf1-regulated gene expression was then examined under chemical stress conditions. The wild-type transformant displayed a characteristic response to tested chemicals as previously reported [3], which can also be viewed in Figure 2A. The chemical induction profile in the fzf1-∆ZF5 transformant in wild-type cells is comparable to that of wild-type cells alone (Figure 2A), except that CY-induced DDI2/3 expression was reduced by 8.5-fold (Figure 3A, p < 0.0001), and the DDI2/3 induction by CY was reduced by 1.7- and 1.9-fold, respectively, in fzf1-C248S (Figure 3B, p = 0.0041) and fzf1-C253S (Figure 3C, p = 0.0014) transformed wild-type cells, while most other gene induction profiles were comparable to wild-type cells. The above observations collectively support the notion that fzf1-ZF5 mutations are recessive and loss-of-function mutations.
It is noticed that in the presence of FZF1, the unique DDI2/3 induction by CY, as observed in the fzf1-C253S mutant (Figure 2D), was undermined (Figure 3C). Meanwhile, NO induced YNR064C by nearly 1000-fold in fzf1-C253S transformed wild-type cells (Figure 3C), in comparison to approximately 60-fold [3] and 150-fold (Figure 2A) when wild-type cells were growing in rich YPD and minimal SD media, respectively. Furthermore, fzf1-C248S (Figure 3B) and empty vector (Supplementary Figure S2) transformed wild-type cells could also support 500-fold induction of YNR064C by NO, indicating that this differential induction is mainly due to the combined effects of cell culture media (rich vs. minimal) and genetic compositions (FZF1 plus different fzf1 alleles).

3.4. fzf1-ZF5 Mutations Are Epistatic to fzf1-ZF4 in Response to Chemical Stresses

Since fzf1-ZF5 mutations abolished the increased basal-level expression of all Fzf1-regulated genes conferred by fzf1-ZF4 mutations, we asked whether fzf1-ZF5 mutations could also eliminate chemical induction of these genes in the fzf1-ZF4 mutant. fzf1-ZF5 mutations not only reversed basal-level increase, but also additional CY-induced DDI2/3 and NO-induced YNR064C expression found in the fzf1-C157S mutant (Figure 4A,B), which allowed us to conclude that fzf1-ZF5 is epistatic to fzf1-ZF4 under both spontaneous and chemical-induced conditions. To our surprise, despite that DDI2/3 and YNR064C were inducible by CY and NO, respectively, in both fzf1-C157S [3] and fzf1-C253S mutant cells (Figure 2D), the fzf1-C157S, C253S double mutation abolished their induction (Figure 4B).
As loss-of-function mutations, one concern was that the mutant form of proteins may not be folded properly and hence affect their cellular levels. We examined in vivo protein levels of C-terminally Flag-tagged single-copy Fzf1 and Fzf1-∆ZF5 under the control of their own promoter and terminator sequences and found that deletion of ZF5 from Fzf1 did not affect its cellular protein level (Figure 5A). While N-terminally Flag-tagged Fzf1-C253S from a single-copy plasmid did not appear to alter its protein stability, the corresponding Fzf1-C248S protein was barely detectable (Figure 5B). Overexpression of the fzf1-C248S allele from a multi-copy plasmid displayed a protein level comparable to those of YCpL-FZF1- and YCpL-fzf1-C253S transformed cells (Figure 5B). Under the above experimental conditions, YEp-fzf1-C248S transformed cells moderately increased basal-level expression of Fzf1-regulated genes indistinguishable from that of YEp-fzf1-C253S (Figure 5C), despite that the latter produced fourfold more protein (Figure 5B).
We also measured Fzf1-regulated gene expression in response to various chemical stresses in YEp-fzf1-C248S transformed fzf1∆ cells. As shown in Figure 5D, these genes were not induced by the tested chemical treatments except that DDI2/3 were induced by CY to nearly 20-fold, reminiscent of the previously reported fzf1-ZF4 mutant cells [3].

3.5. ZF5 Is Dispensable for the Fzf1 Target Sequence CS2 Recognition

Although it was previously reported that three N-terminal ZFs are sufficient to bind its target sequence in the SSU1 promoter, that study employed a 192 bp promoter probe, and the Fzf1 protected region was distinct from the newly defined SSU1-CS2 sequence [18]. To distinguish whether ZF5 acts as a transcription regulatory element or is required for the target DNA recognition, both of which are consistent with the observed fzf1-ZF5 mutant phenotypes so far, we conducted an EMSA to measure the in vitro DNA-binding affinity of recombinant Fzf1 and Fzf1-N117, which lacks ZF4 and ZF5, for one of Fzf1 target sequences, SSU1-CS2. Recombinant Fzf1 was purified as primarily a single protein band as viewed by SDS-PAGE (Supplementary Figure S3), and it formed a single shifted band with FITC-labeled SSU1-SC2 in the EMSA (Figure 6A, arrow). Under the same protein purification conditions, recombinant Fzf1-N117 still contained a few minor bands (Figure S3). Consequently, we normalized the same molar amount of Fzf1 and intact Fzf1-N117 (see Figure S3 legend) in each EMSA reaction with the SSU1-CS2 probe and detected a major shifted band (Figure 6B, upper arrow) indicative of Fzf1-N117 binding and a minor shifted band (Figure 6B, lower arrow) that may contain further truncated Fzf1. The calculated dissociation constant (Kd) for the full-length Fzf1 was around 35 nM (Figure 6C), consistent with a previous report [3]. In comparison, the calculated Kd for Fzf1-N117 was around 30 nM (Figure 6D), demonstrating that the deletion of ZF5 does not compromise Fzf1’s ability to interact with its CS2 recognition sequence.

3.6. The Fzf1-ZF5 Domain Can Function Independently of the Fzf1 DNA-Binding Domain

Based on the above observations, we hypothesized that Fzf1-ZF5 functions as a TAD independently of its DNA-binding domain. To test this hypothesis, we took advantage of the fact that the majority of transcription activators contain at least two independent domains, namely sequence-specific DNA binding and activation, and that the two domains can often be separated and reconstituted [33,34]. We hence fused various Fzf1 fragments to a Gal4 DNA binding domain (Gal4BD) in a yeast two-hybrid vector pGBT9 [30], as shown in Figure 7A, and the resulting plasmids were transformed into a GAL reporter strain pJ69-4a [31]. As anticipated, cells producing Gal4BD alone cannot drive the PGAL1-HIS3 reporter gene expression and hence did not grow on the SD-Trp-His + 1 mM 3AT plate. In contrast, cells expressing full-length Fzf1 fused to Gal4BD grew on the above plate (Figure 7B), indicating that Fzf1 contains a TAD. This TAD in Fzf1 was mapped to ZF5 by detailed truncation analysis, as ZF5 is required and sufficient to activate the PGAL1-HIS3 reporter gene when fused to Gal4BD (Figure 7B). Interestingly, Fzf1-ZF4 in the Gal4BD fusion context did not appear to affect the ZF5 activity, nor did the fzf1-C157S mutation (Figure 7B).
The above plate-based assay, although informative, could not effectively address two questions. Firstly, it could not tell the relative strength of activation by Fzf1-ZF5 in different contexts. Secondly, one could not ask whether and how Fzf1 and its derivatives respond to different chemical stresses when fused to a heterologous DNA-binding domain. We took advantage that pJ69-4a also harbors a PGAL7-lacZ reporter and performed a quantitative β-gal assay. As summarized in Figure 7C, when fused to Gal4BD, ZF5 alone was sufficient to activate PGAL7-lacZ by nearly 200-fold, and ZF4 alone did not confer transcription activation, nor did it repress the ZF5 activity. On the other hand, full-length Fzf1 fused to Gal4BD activated PGAL7-lacZ by more than tenfold, which is sufficient to display a positive result in a plate-based PGAL1-HIS3 reporter assay (Figure 7B), while a C157S substitution further induced PGAL7-lacZ by another tenfold. In all cases, the chemical treatments did not further induce PGAL7-lacZ expression, and the NO treatment even slightly reduced already increased basal-level expression. The only exception was that Gal4BD-Fzf1 mediated MMS induction of PGAL7-lacZ by more than tenfold (p < 0.0001), whose underlying mechanism remains unclear. These observations collectively demonstrate that the Fzf1-ZF5 domain alone can replace Gal4AD in the heterologous context. In addition, ZF4 serves as a repressor of ZF5 only in the presence of the Fzf1 DNA-binding domain.

4. Discussion

This study focused on the functional characterization of ZF5 within the transcription factor Fzf1, and several observations support ZF5 as a stand-alone TAD. Firstly, deletion or point mutations that specifically disrupted the ZF5 domain resulted in loss of Fzf1-mediated chemical induction of its downstream genes. Secondly, the elevated basal-level expression of Fzf1-regulated genes by ZF4 deletion or point mutations is dependent on the intact ZF5 domain. Thirdly, the Fzf1 N-terminal three ZF3 are required and sufficient for the efficient CS2 sequence recognition in vitro, indicating that ZF4 and ZF5 are dispensable for the target DNA-binding activity. Finally, when fused to a Gal4 DNA-binding domain, ZF5 alone functions as a TAD and induces the PGAL7-lacZ reporter gene expression by nearly 200-fold. It was noted that this strongly elevated activity by ZF5 cannot be further induced by the optimal chemical treatments as observed in Fzf1, indicating that ZF5 serves as a stand-alone TAD.
The Fzf1-C248S protein was found to be unstable in host cells, and hence, interpretation of results related to YCpL-fzf1-C248S transformed cells must be cautious. Nevertheless, since both fzf1-∆ZF5 truncation and the fzf1-C253S mutation did not affect cellular protein levels, these results remain sufficient to support our major conclusions in this study. Interestingly, when the cellular Fzf1-C248S protein was brought to a level comparable to Fzf1 by using a multi-copy plasmid, it elevated basal-level expression of Fzf1-targeted genes indistinguishable from that of YEpL-fzf1-C253S transformed cells, indicating that Fzf1-C248S and Fzf1-C253S function similarly. Collectively, these two C-to-S substitutions abolished ZF5’s transactivation activity but not the remaining CY-induced DDI2/3 and NO-induced YNR064C expression, which appear to be dependent on Fzf1 but independent of its TAD.
Based on the observed genetic relationships among FZF1, fzf1-ZF4, and fzf1-ZF5, we propose a working model (Figure 8), in which Fzf1 binds its CS2 sequence in the promoters of its regulated genes, including DDI2/3, YHB1, SSU1, and YNR064C. However, under uninduced conditions, the ZF5-mediated transcription activation activity is inhibited by ZF4, while the chemical stresses relieve such an inhibition, resulting in ZF5 derepression and the Fzf1 target gene induction. Hence, the chemical stress-induced activation of Fzf1 is at least partially achieved by derepression (Figure 8). Our recent studies [13,14] indicate that chemical stresses like CY and MMS also enhance Fzf1 binding to its target CS2 sequence in vitro and in vivo, although the underlying molecular mechanisms by which chemical stresses relieve ZF4 inhibition remain unclear. It is noted that when fused to Gal4BD, the full-length Fzf1 only activated the PGAL7-lacZ reporter by tenfold, suggesting that the ZF5 activity is still largely inhibited in its native conformation. Indeed, this inhibition can be relieved by a fzf1-ZF4 mutation. Furthermore, this inhibition can also be relieved by MMS, but not by CY or NO treatment. In this context, it is interesting to note that the purified Fzf1 protein can be methylated by MMS at its K70 residue in vitro, and an fzf1-K70A mutation abolishes MMS-induced DDI2/3 expression [13]. Since K70 is located within the Fzf1 DNA-binding domain, it explains why this domain is required to sense Lys methylation by MMS. In contrast, the Gal4BD belongs to a Zn2Cys6 family [35] that adopts a structure different from the C2H2 Fzf1BD and hence may not sense chemical stresses. Like MMS, which can methylate Lys or Arg residues in protein [36], CY can also modify a Lys residue to form homoarginine [37], and a Cys residue can be S-nitrosylated by NO [38,39,40] to alter the protein activity. Apparently, CY- and NO-mediated Fzf1 activation mechanisms cannot be recapitulated in the Gal4BD fusion system and must be different from MMS-mediated Fzf1 activation, which requires further investigation. On the other hand, the full-length Fzf1 conformation appears to be required for ZF4 to inhibit the ZF5 activity, since, when fused to Gal4BD, an Fzf1 C-terminal peptide containing both ZF4 and ZF5 behaves like ZF5 alone. Similarly, an fzf1-ZF4 mutation in this fusion construct did not further induce the PGAL7-lacZ reporter activity, indicating that this C-terminal region either does not contain a chemical sensor, or ZF4 alone is insufficient to repress the ZF5 activity.
TADs typically lack conserved sequence motifs. Nevertheless, certain structural and sequence features have been identified among various TADs, including acidic/nine-amino-acid TAD (9aaTAD), glutamine-rich domains, serine/threonine-rich domains, proline-rich domains, and isoleucine-rich domains [41,42]. For example, the budding yeast Msn2 9aaTAD interacts with Gal11/Med15, a component of the Mediator complex [43,44]. Mammalian Sp1 contains glutamine-rich and serine/threonine-rich regions to facilitate interactions with various transcriptional co-regulators, including TATA-binding protein (TBP), TAF4 (a TFIID subunit), and chromatin-modifying proteins such as the histone acetyltransferase p300 [17,45]. Mammalian CTF/NF-1 contains both proline-rich and isoleucine-rich domains that interact with components of general transcriptional initiation proteins, including TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and other subunits of preinitiation complex (PIC) as well [46,47]. Although we are not aware of a reported case in which a ZF domain serves as a TAD, C2H2-type ZF domains are known to not only bind DNA and RNA, but also mediate protein–protein interaction [48], making it possible for ZF5 to interact with and recruit general transcriptional factors to the Fzf1 target gene promoters. We speculate that this interaction must be sequence specific, since Fzf1-ZF4 cannot replace the ZF5 activity. In contrast, ZF4 in its native conformation may block such an access until receiving chemical stress signals (Figure 8).

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jof12010015/s1, Figure S1. The amino acid sequence of Fzf1. This sequence was translated from the sequenced FZF1 ORF used in this study, which also agrees with the Saccharomyces Genome Database. Five C2H2 zinc fingers are highlighted and labeled, and critical residues substituted in this study are in green. Figure S2. Relative YNR064C transcript levels upon 2 mM DPTA NONOate (NO) treatment. BY4741 wildtype cells were transformed with a YCplac111 empty vector and the transformant was treated with indicated chemical for 1.5 hour followed by a qRT-PCR assay. The data are the average of at least three independent experiments, with standard deviations shown as error bars. Figure S3. SDS-PAGE analysis of recombinant Fzf1 and Fzf1-N117 proteins. Recombinant Fzf1 protein yielded one predominant band, whose protein concentration was measured by Nano-drop and converted to molar value based on its calculated molecular weight. In contrast, the recombinant Fzf1-N117 protein sample contained several minor bands despite repeated attempts of purification. The concentration of the intact Fzf1-N117 band was measured by densitometry in comparison to that of known Fzf1 concentration and then converted to molar value taken into consideration of molecular weight difference. Each lane contains 3.25 μM of the anticipated protein. Molecular weight markers are shown on left. Table S1. Plasmids used in this study. Table S2. Oligonucleotides used in this study.

Author Contributions

Conceptualization, Y.D. and W.X.; experiments, Y.D. and W.Y.W.; data analysis, Y.D. and W.X.; writing—original draft preparation, Y.D.; review and revision, W.X.; supervision, W.X.; funding requisition, W.X. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Natural Sciences and Engineering Research Council of Canada Discovery Grants RGPIN-2019-05604 and RGPIN-2025-06661 to W.X.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Acknowledgments

We thank Wei Li from the Institute of Zoology, Chinese Academy of Sciences, for the anti-Pgk1 antibody, Stan Moore from the University of Saskatchewan, and the Xiao laboratory members for the helpful discussion.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Breitwieser, W.; Price, C.; Schuster, T. Identification of a gene encoding a novel zinc finger protein in Saccharomyces cerevisiae. Yeast 1993, 9, 551–556. [Google Scholar] [CrossRef] [PubMed]
  2. Sarver, A.; DeRisi, J. Fzf1p regulates an inducible response to nitrosative stress in Saccharomyces cerevisiae. Mol. Biol. Cell 2005, 16, 4781–4791. [Google Scholar] [CrossRef]
  3. Du, Y.; Ma, C.; Moore, S.A.; Xiao, W. Zinc finger 4 negatively controls the transcriptional activator Fzf1 in Saccharomyces cerevisiae. mLife 2024, 3, 391–402. [Google Scholar] [CrossRef]
  4. Avram, D.; Bakalinsky, A.T. SSU1 encodes a plasma membrane protein with a central role in a network of proteins conferring sulfite tolerance in Saccharomyces cerevisiae. J. Bacteriol. 1997, 179, 5971–5974. [Google Scholar] [CrossRef]
  5. Buisson, N.; Labbe-Bois, R. Flavohemoglobin expression and function in Saccharomyces cerevisiae. No relationship with respiration and complex response to oxidative stress. J. Biol. Chem. 1998, 273, 9527–9533. [Google Scholar] [CrossRef]
  6. Horan, S.; Bourges, I.; Meunier, B. Transcriptional response to nitrosative stress in Saccharomyces cerevisiae. Yeast 2006, 23, 519–535. [Google Scholar] [CrossRef]
  7. Maier-Greiner, U.H.; Obermaier-Skrobranek, B.M.; Estermaier, L.M.; Kammerloher, W.; Freund, C.; Wulfing, C.; Burkert, U.I.; Matern, D.H.; Breuer, M.; Eulitz, M.; et al. Isolation and properties of a nitrile hydratase from the soil fungus Myrothecium verrucaria that is highly specific for the fertilizer cyanamide and cloning of its gene. Proc. Natl. Acad. Sci. USA 1991, 88, 4260–4264. [Google Scholar] [CrossRef] [PubMed]
  8. Li, J.; Biss, M.; Fu, Y.; Xu, X.; Moore, S.A.; Xiao, W. Two duplicated genes DDI2 and DDI3 in budding yeast encode a cyanamide hydratase and are induced by cyanamide. J. Biol. Chem. 2015, 290, 12664–12675. [Google Scholar] [CrossRef] [PubMed]
  9. Lin, A.; Zeng, C.; Wang, Q.; Zhang, W.; Li, M.; Hanna, M.; Xiao, W. Utilization of a Strongly Inducible DDI2 Promoter to Control Gene Expression in Saccharomyces cerevisiae. Front. Microbiol. 2018, 9, 2736. [Google Scholar] [CrossRef]
  10. Fu, Y.; Zhu, Y.; Zhang, K.; Yeung, M.; Durocher, D.; Xiao, W. Rad6-Rad18 mediates a eukaryotic SOS response by ubiquitinating the 9-1-1 checkpoint clamp. Cell 2008, 133, 601–611. [Google Scholar] [CrossRef]
  11. Zhang, F.; Bartels, M.J.; Pottenger, L.H.; Gollapudi, B.B. Differential adduction of proteins vs. deoxynucleosides by methyl methanesulfonate and 1-methyl-1-nitrosourea in vitro. Rapid Commun. Mass. Spectrom. 2005, 19, 438–448. [Google Scholar] [CrossRef]
  12. Elfstrom, L.T.; Widersten, M. The Saccharomyces cerevisiae ORF YNR064c protein has characteristics of an ‘orphaned’ epoxide hydrolase. Biochim. Biophys. Acta 2005, 1748, 213–221. [Google Scholar] [CrossRef] [PubMed]
  13. Lin, A.; Chumala, P.; Du, Y.; Ma, C.; Wei, T.; Xu, X.; Luo, Y.; Katselis, G.S.; Xiao, W. Transcriptional activation of budding yeast DDI2/3 through chemical modifications of Fzf1. Cell Biol. Toxicol. 2023, 39, 1531–1547. [Google Scholar] [CrossRef]
  14. Ma, C.; Du, Y.; Xiao, W.; Moore, S.A. Zn-finger transcription factor Fzf1 binds to its target DNA in a non-canonical manner. Nucleic Acids Res. 2025. in revision. [Google Scholar]
  15. Laity, J.H.; Lee, B.M.; Wright, P.E. Zinc finger proteins: New insights into structural and functional diversity. Curr. Opin. Struct. Biol. 2001, 11, 39–46. [Google Scholar] [CrossRef]
  16. Aceituno-Valenzuela, U.; Micol-Ponce, R.; Ponce, M.R. Genome-wide analysis of CCHC-type zinc finger (ZCCHC) proteins in yeast, Arabidopsis, and humans. Cell Mol. Life Sci. 2020, 77, 3991–4014. [Google Scholar] [CrossRef]
  17. Razin, S.V.; Borunova, V.V.; Maksimenko, O.G.; Kantidze, O.L. Cys2His2 zinc finger protein family: Classification, functions, and major members. Biochemistry 2012, 77, 217–226. [Google Scholar] [CrossRef] [PubMed]
  18. Avram, D.; Leid, M.; Bakalinsky, A.T. Fzf1p of Saccharomyces cerevisiae is a positive regulator of SSU1 transcription and its first zinc finger region is required for DNA binding. Yeast 1999, 15, 473–480. [Google Scholar] [CrossRef]
  19. Casalone, E.; Colella, C.M.; Daly, S.; Fontana, S.; Torricelli, I.; Polsinelli, M. Cloning and characterization of a sulphite-resistance gene of Saccharomyces cerevisiae. Yeast 1994, 10, 1101–1110. [Google Scholar] [CrossRef]
  20. Nasuno, R.; Yoshioka, N.; Yoshikawa, Y.; Takagi, H. Cysteine residues in the fourth zinc finger are important for activation of the nitric oxide-inducible transcription factor Fzf1 in the yeast Saccharomyces cerevisiae. Genes. Cells 2021, 26, 823–829. [Google Scholar] [CrossRef]
  21. Sherman, F.; Fink, G.R.; Hicks, J. Methods in Yeast Genetics; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 1983. [Google Scholar]
  22. Liu, H.; Naismith, J.H. An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 2008, 8, 91. [Google Scholar] [CrossRef] [PubMed]
  23. Ito, H.; Fukuda, Y.; Murata, K.; Kimura, A. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 1983, 153, 163–168. [Google Scholar] [CrossRef]
  24. Gietz, R.D.; Woods, R.A. Yeast transformation by the LiAc/SS Carrier DNA/PEG method. Methods Mol. Biol. 2006, 313, 107–120. [Google Scholar]
  25. Xu, X.; Lambrecht, A.D.; Xiao, W. In Yeast Protocols, Xiao, W., Ed.; Yeast survival and growth assays, 3rd ed.; Humana Press: New York, NY, USA, 2014; Volume 1163, pp. 183–191. [Google Scholar]
  26. Schmittgen, T.D.; Livak, K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3, 1101–1108. [Google Scholar] [CrossRef] [PubMed]
  27. Gietz, R.D.; Sugino, A. New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 1988, 74, 527–534. [Google Scholar] [CrossRef] [PubMed]
  28. Wang, Q.; Xue, H.; Li, S.; Chen, Y.; Tian, X.; Xu, X.; Xiao, W.; Fu, Y.V. A method for labeling proteins with tags at the native genomic loci in budding yeast. PLoS ONE 2017, 12, e0176184. [Google Scholar] [CrossRef]
  29. Ball, L.G.; Xiao, W. Xiao, W., Ed.; Detection of protein posttranslational modifications from whole-cell extracts in Saccharomyces cerevisiae. In Yeast Protocols, 3rd ed.; Humana Press: New York, NY, USA, 2014; Volume 1163, pp. 249–255. [Google Scholar]
  30. Fields, S.; Song, O. A novel genetic system to detect protein-protein interactions. Nature 1989, 340, 245–246. [Google Scholar] [CrossRef]
  31. James, P.; Halladay, J.; Craig, E.A. Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 1996, 144, 1425–1436. [Google Scholar] [CrossRef]
  32. Biss, M.; Xiao, W. Yan, Z., Caldwell, G.W., Eds.; Assessing DNA damage using a reporter gene system. In Optimization in Drug Discovery; Humana Press: Totowa, NJ, USA, 2014. [Google Scholar]
  33. Ma, J. Transcriptional activators and activation mechanisms. Protein Cell 2011, 2, 879–888. [Google Scholar] [CrossRef]
  34. Ptashne, M. How eukaryotic transcriptional activators work. Nature 1988, 335, 683–689. [Google Scholar] [CrossRef]
  35. Marmorstein, R.; Carey, M.; Ptashne, M.; Harrison, S.C. DNA recognition by GAL4: Structure of a protein-DNA complex. Nature 1992, 356, 408–414. [Google Scholar] [CrossRef]
  36. Paik, W.K.; DiMaria, P.; Kim, S.; Magee, P.N.; Lotlikar, P.D. Alkylation of protein by methyl methanesulfonate and 1-methyl-1-nitrosourea in vitro. Cancer Lett. 1984, 23, 9–17. [Google Scholar] [CrossRef]
  37. Amberger, A. Cyanamide in plant metabolism. Int. J. Plant Physiol. Biochem. 2013, 5, 1–10. [Google Scholar]
  38. Chen, Y.Y.; Chu, H.M.; Pan, K.T.; Teng, C.H.; Wang, D.L.; Wang, A.H.; Khoo, K.H.; Meng, T.C. Cysteine S-nitrosylation protects protein-tyrosine phosphatase 1B against oxidation-induced permanent inactivation. J. Biol. Chem. 2008, 283, 35265–35272. [Google Scholar] [CrossRef]
  39. Cui, B.; Pan, Q.; Clarke, D.; Villarreal, M.O.; Umbreen, S.; Yuan, B.; Shan, W.; Jiang, J.; Loake, G.J. S-nitrosylation of the zinc finger protein SRG1 regulates plant immunity. Nat. Commun. 2018, 9, 4226. [Google Scholar] [CrossRef]
  40. Hess, D.T.; Matsumoto, A.; Kim, S.O.; Marshall, H.E.; Stamler, J.S. Protein S-nitrosylation: Purview and parameters. Nat. Rev. Mol. Cell Biol. 2005, 6, 150–166. [Google Scholar] [CrossRef] [PubMed]
  41. Erkine, A.M.; Oliveira, M.A.; Class, C.A. The Enigma of Transcriptional Activation Domains. J. Mol. Biol. 2024, 436, 168766. [Google Scholar] [CrossRef]
  42. Udupa, A.; Kotha, S.R.; Staller, M.V. Commonly asked questions about transcriptional activation domains. Curr. Opin. Struct. Biol. 2024, 84, 102732. [Google Scholar] [CrossRef]
  43. Sadeh, A.; Baran, D.; Volokh, M.; Aharoni, A. Conserved motifs in the Msn2-activating domain are important for Msn2-mediated yeast stress response. J. Cell Sci. 2012, 125, 3333–3342. [Google Scholar] [CrossRef]
  44. Piskacek, M.; Havelka, M.; Rezacova, M.; Knight, A. The 9aaTAD Transactivation Domains: From Gal4 to p53. PLoS ONE 2016, 11, e0162842. [Google Scholar] [CrossRef]
  45. Beishline, K.; Azizkhan-Clifford, J. Sp1 and the ‘hallmarks of cancer’. FEBS J. 2015, 282, 224–258. [Google Scholar] [CrossRef]
  46. Williamson, M.P. The structure and function of proline-rich regions in proteins. Biochem. J. 1994, 297, 249–260. [Google Scholar] [CrossRef] [PubMed]
  47. Mermod, N.; O’Neill, E.A.; Kelly, T.J.; Tjian, R. The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell 1989, 58, 741–753. [Google Scholar] [CrossRef]
  48. Iuchi, S. Three classes of C2H2 zinc finger proteins. Cell Mol. Life Sci. 2001, 58, 625–635. [Google Scholar] [CrossRef]
Figure 1. Phenotypes of fzf1-ZF5 mutants. (A) Schematic illustration of different Fzf1 mutations produced by a single-copy YCp plasmid. Amino acid locations of ZF domains, substitutions, and truncation sites are indicated. (B) Relative basal-level expression of Fzf1-regulated genes in fzf1-ZF5 mutants. YCpL plasmids carrying the indicated fzf1 mutant alleles were transformed into fzf1∆ cells, and the transformants were subjected to a qRT-PCR assay. (C) Relative sensitivity of fzf1 amino acid substitution mutants to sodium sulfite. (D) Relative sensitivity of fzf1 truncation mutants to sodium sulfite. (C,D) YCp plasmids carrying the indicated fzf1 mutant alleles were transformed into wild-type or fzf1∆ cells, and the transformants were subjected to a serial dilution assay. Plates were incubated at 30 °C for three days before photography.
Figure 1. Phenotypes of fzf1-ZF5 mutants. (A) Schematic illustration of different Fzf1 mutations produced by a single-copy YCp plasmid. Amino acid locations of ZF domains, substitutions, and truncation sites are indicated. (B) Relative basal-level expression of Fzf1-regulated genes in fzf1-ZF5 mutants. YCpL plasmids carrying the indicated fzf1 mutant alleles were transformed into fzf1∆ cells, and the transformants were subjected to a qRT-PCR assay. (C) Relative sensitivity of fzf1 amino acid substitution mutants to sodium sulfite. (D) Relative sensitivity of fzf1 truncation mutants to sodium sulfite. (C,D) YCp plasmids carrying the indicated fzf1 mutant alleles were transformed into wild-type or fzf1∆ cells, and the transformants were subjected to a serial dilution assay. Plates were incubated at 30 °C for three days before photography.
Jof 12 00015 g001
Figure 2. Relative transcript levels of Fzf1-regulated genes in yeast fzf1-ZF5 mutants under chemical treatment conditions. (A) Wild-type FZF1. (B) fzf1-∆ZF5. (C) fzf1-C248S. (D) fzf1-C253S. YCp plasmids carrying the indicated fzf1 mutant alleles were transformed into BY4741 fzf1∆ cells, and the transformants were subjected to chemical treatments followed by qRT-PCR assays. All values were relative to the corresponding fzf1 mutant alleles without chemical treatment (magenta bars). The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Figure 2. Relative transcript levels of Fzf1-regulated genes in yeast fzf1-ZF5 mutants under chemical treatment conditions. (A) Wild-type FZF1. (B) fzf1-∆ZF5. (C) fzf1-C248S. (D) fzf1-C253S. YCp plasmids carrying the indicated fzf1 mutant alleles were transformed into BY4741 fzf1∆ cells, and the transformants were subjected to chemical treatments followed by qRT-PCR assays. All values were relative to the corresponding fzf1 mutant alleles without chemical treatment (magenta bars). The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Jof 12 00015 g002
Figure 3. Relative transcript levels of Fzf1-regulated genes in yeast cells carrying both wild-type and fzf1-ZF5 mutant alleles under chemical treatment conditions. (A) fzf1-∆ZF5. (B) fzf1-C248S. (C) fzf1-C253S. YCp plasmids carrying the indicated fzf1 mutant alleles were transformed into BY4741 cells, and the transformants were subjected to chemical treatments followed by qRT-PCR assays. The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Figure 3. Relative transcript levels of Fzf1-regulated genes in yeast cells carrying both wild-type and fzf1-ZF5 mutant alleles under chemical treatment conditions. (A) fzf1-∆ZF5. (B) fzf1-C248S. (C) fzf1-C253S. YCp plasmids carrying the indicated fzf1 mutant alleles were transformed into BY4741 cells, and the transformants were subjected to chemical treatments followed by qRT-PCR assays. The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Jof 12 00015 g003
Figure 4. Relative transcript levels of Fzf1-regulated genes in yeast fzf1-ZF4,5 double mutants under chemical treatment conditions. (A) fzf1-C157S,C248S. (B) fzf1-C157S,C253S. YCp plasmids carrying the indicated fzf1 mutant alleles were transformed into BY4741 fzf1∆ cells, and the transformants were subjected to chemical treatments followed by qRT-PCR assays. The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Figure 4. Relative transcript levels of Fzf1-regulated genes in yeast fzf1-ZF4,5 double mutants under chemical treatment conditions. (A) fzf1-C157S,C248S. (B) fzf1-C157S,C253S. YCp plasmids carrying the indicated fzf1 mutant alleles were transformed into BY4741 fzf1∆ cells, and the transformants were subjected to chemical treatments followed by qRT-PCR assays. The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Jof 12 00015 g004
Figure 5. Assessment of cellular Fzf1-derived protein levels. (A) C-terminally 3xFlag-tagged Fzf1-∆ZF5 protein. (B) N-terminally 3xFlag-tagged Fzf1-C248S and Fzf1-253S proteins. Values are relative to YCp-Fzf1 transformants as measured by densitometry, normalized to the corresponding Pgk1 level. (A,B) YCp or YEp plasmids carrying wild-type or indicated fzf1-∆ZF5 mutant allele fused to a 3xFlag tag were transformed into BY4741 fzf1∆ mutant cells, and the transformants were subjected to Western blot analysis against anti-Flag (upper panel) and anti-Pgk1(lower panel) antibodies. (C) Relative transcript levels of Fzf1-regulated genes in the indicated fzf1 mutant cells. (D) Relative transcript levels of Fzf1-regulated genes under chemical treatment conditions. Plasmids carrying indicated fzf1 mutant alleles were transformed into BY4741 fzf1∆ cells, and the transformants were untreated (C) or treated with indicated chemicals followed by qRT-PCR assays. The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Figure 5. Assessment of cellular Fzf1-derived protein levels. (A) C-terminally 3xFlag-tagged Fzf1-∆ZF5 protein. (B) N-terminally 3xFlag-tagged Fzf1-C248S and Fzf1-253S proteins. Values are relative to YCp-Fzf1 transformants as measured by densitometry, normalized to the corresponding Pgk1 level. (A,B) YCp or YEp plasmids carrying wild-type or indicated fzf1-∆ZF5 mutant allele fused to a 3xFlag tag were transformed into BY4741 fzf1∆ mutant cells, and the transformants were subjected to Western blot analysis against anti-Flag (upper panel) and anti-Pgk1(lower panel) antibodies. (C) Relative transcript levels of Fzf1-regulated genes in the indicated fzf1 mutant cells. (D) Relative transcript levels of Fzf1-regulated genes under chemical treatment conditions. Plasmids carrying indicated fzf1 mutant alleles were transformed into BY4741 fzf1∆ cells, and the transformants were untreated (C) or treated with indicated chemicals followed by qRT-PCR assays. The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Jof 12 00015 g005
Figure 6. EMSA assessment of sequence-specific interactions of Fzf1 and Fzf1-N117 with an SSU1-CS2. (A,B) Representative EMSA images showing Fzf1 (A) or Fzf1-N117 (B) interaction with an FITC-labeled SSU1-CS2 probe. Triangles on top indicate increasing protein concentrations in lanes 1–14: 0, 7.5, 15, 22.5, 30, 37.5, 45, 60, 75, 90, 105, 120, 135, and 150 nM. Arrows point to anticipated protein-DNA complexes. (C,D) Quantitative analysis of Fzf1 (C) and Fzf1-N117 (D) binding affinity for the SSU1-CS2 probe. Kd values were calculated as described in Materials and Methods based on three independent EMSA images, with standard deviations shown as error bars.
Figure 6. EMSA assessment of sequence-specific interactions of Fzf1 and Fzf1-N117 with an SSU1-CS2. (A,B) Representative EMSA images showing Fzf1 (A) or Fzf1-N117 (B) interaction with an FITC-labeled SSU1-CS2 probe. Triangles on top indicate increasing protein concentrations in lanes 1–14: 0, 7.5, 15, 22.5, 30, 37.5, 45, 60, 75, 90, 105, 120, 135, and 150 nM. Arrows point to anticipated protein-DNA complexes. (C,D) Quantitative analysis of Fzf1 (C) and Fzf1-N117 (D) binding affinity for the SSU1-CS2 probe. Kd values were calculated as described in Materials and Methods based on three independent EMSA images, with standard deviations shown as error bars.
Jof 12 00015 g006
Figure 7. Mapping of the transcription activation domain within Fzf1 by yeast reporter gene assays. (A) Schematic illustration of different Fzf1 regions fused to a Gal4 DNA-binding domain (Gal4BD) in plasmid vector pGBT9. Amino acid locations of ZF domains and truncation sites are indicated. Plasmid pGBT9 and its FZF1 fusion constructs were used to transform yeast PJ69-4A cells, and the transformants were subjected to the indicated reporter gene assays. (B) A plate-based PGAL1-HIS3 reporter assay. The plates were incubated at 30 °C for 2 days before photography. Only one representative plate is shown. (C) A PGAL7-lacZ reporter assay that measures β-galactosidase activity. The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Figure 7. Mapping of the transcription activation domain within Fzf1 by yeast reporter gene assays. (A) Schematic illustration of different Fzf1 regions fused to a Gal4 DNA-binding domain (Gal4BD) in plasmid vector pGBT9. Amino acid locations of ZF domains and truncation sites are indicated. Plasmid pGBT9 and its FZF1 fusion constructs were used to transform yeast PJ69-4A cells, and the transformants were subjected to the indicated reporter gene assays. (B) A plate-based PGAL1-HIS3 reporter assay. The plates were incubated at 30 °C for 2 days before photography. Only one representative plate is shown. (C) A PGAL7-lacZ reporter assay that measures β-galactosidase activity. The data are the average of at least three independent experiments, with standard deviations shown as error bars.
Jof 12 00015 g007
Figure 8. Illustration of a proposed model for Fzf1-mediated transcriptional activation of downstream genes in response to chemical stresses. In this model, the DNA-binding domain consisting of the first three ZFs (ZF1-3) of Fzf1 binds CS2 at its target gene promoters. In the absence of chemical stress, the ZF4 domain interferes with ZF5, preventing it from interacting with the transcription initiation complex (TIC), thereby repressing transcription initiation. Chemical treatments by CY, MMS, or NO cause Fzf1 post-translational modifications (e.g., Lys70 methylation by MMS treatment) that enhance its binding to CS2 and also cause conformational changes to relieve this inhibition, enabling ZF5 to recruit the TIC and ultimately initiate transcription of Fzf1 target genes.
Figure 8. Illustration of a proposed model for Fzf1-mediated transcriptional activation of downstream genes in response to chemical stresses. In this model, the DNA-binding domain consisting of the first three ZFs (ZF1-3) of Fzf1 binds CS2 at its target gene promoters. In the absence of chemical stress, the ZF4 domain interferes with ZF5, preventing it from interacting with the transcription initiation complex (TIC), thereby repressing transcription initiation. Chemical treatments by CY, MMS, or NO cause Fzf1 post-translational modifications (e.g., Lys70 methylation by MMS treatment) that enhance its binding to CS2 and also cause conformational changes to relieve this inhibition, enabling ZF5 to recruit the TIC and ultimately initiate transcription of Fzf1 target genes.
Jof 12 00015 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Du, Y.; Wang, W.Y.; Xiao, W. Zinc-Finger 5 Is an Activation Domain in the Saccharomyces cerevisiae Stress-Responsive Transcription Factor Fzf1. J. Fungi 2026, 12, 15. https://doi.org/10.3390/jof12010015

AMA Style

Du Y, Wang WY, Xiao W. Zinc-Finger 5 Is an Activation Domain in the Saccharomyces cerevisiae Stress-Responsive Transcription Factor Fzf1. Journal of Fungi. 2026; 12(1):15. https://doi.org/10.3390/jof12010015

Chicago/Turabian Style

Du, Ying, Wayne Y. Wang, and Wei Xiao. 2026. "Zinc-Finger 5 Is an Activation Domain in the Saccharomyces cerevisiae Stress-Responsive Transcription Factor Fzf1" Journal of Fungi 12, no. 1: 15. https://doi.org/10.3390/jof12010015

APA Style

Du, Y., Wang, W. Y., & Xiao, W. (2026). Zinc-Finger 5 Is an Activation Domain in the Saccharomyces cerevisiae Stress-Responsive Transcription Factor Fzf1. Journal of Fungi, 12(1), 15. https://doi.org/10.3390/jof12010015

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop